MeSH tree: C04.557.470.200.025.255
Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel platform reflects the ...
Sep 4, 2025
0
16
Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world's most widespread diseases and a top cause of liver cancer around the globe.
Sep 3, 2025
0
12
Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumor progression in response to standard treatment, according to a new study led by the University ...
Aug 26, 2025
0
22
Determining whether a cancerous tumor originated in a given location or spread there from another tissue or organ in the body is important when assessing the likely course of a patient's disease. When the origin of the primary ...
Aug 14, 2025
0
12
Researchers from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have made a significant advancement that could reshape the treatment landscape for hepatocellular carcinoma ...
Aug 13, 2025
0
29
Among the many forms of liver cancer, hepatocellular carcinoma (HCC) is the most common and one of the leading causes of cancer-related deaths worldwide. It is a complex disease with multiple aggressive subtypes that are ...
Aug 11, 2025
0
22
Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease. But researchers at McMaster University in collaboration with Espervita Therapeutics have ...
Jul 30, 2025
0
344
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease—previously called non-alcoholic fatty liver ...
Jul 28, 2025
0
87
In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B.
Jul 24, 2025
0
16
A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma (uHCC, an advanced liver cancer that could not be treated with surgery or other localized treatments) ...
Jul 22, 2025
0
14
